
Karl Lewis, MD, medical oncologist, associate professor, University of Colorado, discusses sequencing immunotherapy and targeted therapy for patients with melanoma.

Your AI-Trained Oncology Knowledge Connection!


Published: October 2nd 2013 | Updated:

Published: October 15th 2013 | Updated: